Videos

Treatment Advancements Happening in Lung Cancer As Unmet Needs Remain

November 24th 2023, 8:00pm

Video

As part of its Speaking Out® video series, CURE® spoke Dr. Gene G. Finley of Drexel University of College of Medicine and AHN Cancer Institute, Allegheny Clinic Medical Oncology, about advancements in treating non-small cell lung cancer and the unmet needs that persist for patients.

“Lung Cancer Is a Really Sneaky Beast”: Why patients need to remain vigilant with scans, even while dealing with “scanxiety.”

November 24th 2023, 8:00pm

Video

As part of its Speaking Out® video series, CURE® spoke with Dusty Joy Donaldson of LiveLung/The Dusty Joy Foundation and Lung Cancer Action Network about her lung cancer journey and the importance of scans.

‘It Can Happen to Anybody’: Lung Cancer Survivor Shares Radon Exposure Story

November 24th 2023, 8:00pm

Video

As part of its Speaking Out® video series, CURE® spoke with Kimberly Buchmeier, a lung cancer survivor and board member of LiveLung.

Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist

November 22nd 2023, 1:30pm

Video

Clinical trials should be considered at any point in a patient's journey with HER2-positive metastatic breast cancer, not just when standard options are exhausted, as they provide early access to promising therapies, novel combinations, and cutting-edge care.

Factors Informing Individualized Treatment Decision-Making for HER2-Positive Metastatic Breast Cancer

November 22nd 2023, 1:00pm

Video

Sara M. Tolaney, MD, MPH explains that treatment decisions for metastatic breast cancer are based on the current biopsy showing receptor status, but prior biopsies over the full course of disease are considered as well, particularly for HER2 targeted therapies which may work even if HER2 low expression occurred years earlier.

Unmet Needs in the Cervical Cancer Treatment Landscape

November 21st 2023, 3:46pm

Video

The panel discusses unmet needs in the treatment landscape for patients with cervical cancer and the importance of clinical trials.

Tisotumab Vedotin for Patients With Cervical Cancer

November 21st 2023, 3:21pm

Video

Comprehensive insights on the journey of a patient with cervical cancer and treatment options upon progression, with a focus on tisotumab vedotin.

CURE Webinar on Diversity, Equity and Inclusion in Prostate Cancer

November 17th 2023, 8:00pm

Video

In conjunction with ZERO — The End of Prostate Cancer, CURE® recently hosted the “Educated Patient® Webinar: Advancing Equity in Prostate Cancer Care.”

Necessary Tests After a Diagnosis of Breast Cancer

November 15th 2023, 4:59pm

Video

Sara M. Tolaney, MD, MPH, states that all breast cancers should be tested for estrogen, progesterone, and HER2 receptors; HER2 testing involves an immunohistochemistry stain to quantify protein levels, with 3+ indicating HER2+ disease, 0 indicating HER2- disease, and 1-2+ levels needing additional FISH testing to clarify HER2 status.

The Role of the HER2 Receptor in Breast Cancer

November 15th 2023, 4:49pm

Video

Sara M. Tolaney, MD, MPH, introduces the role of HER2 as a breast cancer cell growth receptor and explains HER2-positive versus HER2-negative.